Aortic Valve Insufficiency – Page 5

Eli Lilly and insitro Collaborate on AI-Driven Metabolic Disease Therapies

8 months ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, Biotechnology, Drug Discovery, Eli, Eli Lilly, GalNAc, Insitro, Metabolic Diseases, pharmaceutical partnership, RNA, Small Interfering

Eli Lilly, insitro, AI, metabolic diseases, siRNA, GalNAc, drug discovery, biotechnology, pharmaceutical partnership

Basecamp Research Secures $60M to Revolutionize AI Drug Discovery with Broad Institute Partnership

8 months ago talkbio0Tagged Aortic Valve Insufficiency, Artificial (qualifier value), biology (field), Biotechnology, Broad Institute, gene therapy, IMMUNODEFICIENCY, COMMON VARIABLE, 10, R. Liu, research

AI drug discovery, Basecamp Research, Broad Institute, David R. Liu, Biotechnology, Gene therapy, Artificial intelligence in biology

Eli Lilly and Insitro Collaborate on AI-Driven Therapies for Metabolic Diseases

8 months ago talkbio0Tagged Agreement, Antibody Therapy, Aortic Valve Insufficiency, Artificial Intelligence, Drug Development, Eli, Eli Lilly, Insitro, MASLD, Metabolic, Metabolic Diseases, RNA, Small Interfering, steatotic liver disease, strategic

Eli Lilly, Insitro, AI, Metabolic Diseases, Drug Development, Strategic Agreements, siRNA Therapies, Antibody Therapy, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)